Clinical Trials Browser

Phase 1/2 × NETWORK × silmitasertib × Clear all

NCT03904862 2025-10-30

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Phase 1/2 Terminated

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma